Missing/wrong data?
Log in to edit
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.
scientific article
Author/s
author: Anthony O'Hagan, Karl Claxton, Keith R. Abrams, James Chilcott, Paul Tappenden, David H. Miller
Work details
Publication date
March 1, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.